Status:
COMPLETED
Zilver PTX Post-Market Study in Japan
Lead Sponsor:
Cook Group Incorporated
Conditions:
Peripheral Arterial Disease (PAD)
Eligibility:
All Genders
Phase:
NA
Brief Summary
Japanese post market clinical study of the Zilver PTX device.
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Symptomatic peripheral arterial disease (PAD) involving the above-the-knee femoropopliteal arteries
Exclusion
Key Trial Info
Start Date :
May 1 2012
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 30 2018
Estimated Enrollment :
909 Patients enrolled
Trial Details
Trial ID
NCT02254837
Start Date
May 1 2012
End Date
June 30 2018
Last Update
July 12 2019
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.